Investigation of a new amoxicillin sodium impurity unstable in solution.
A new amoxicillin sodium impurity was detected by reversed-phase HPLC in commercial injectable preparations only when examined very soon after the drug was dissolved in the solvent vial (within about 10 min). The stability of this impurity was investigated by the degradation kinetic of its aqueous solutions. Ionspray mass spectrometry with flow-injection analysis and HPLC-MS methods were used to establish its nature. Some hypotheses concerning its chemical structure were formulated. The most likely assumption referred to the (5S,6R) amoxicillin piperazinedione diasteroisomer. The presence of the amoxicilloic acid methyl ester, an intermediate of the amoxicillin degradation process, was also hypothesized.
Valvo
L
L
Pharmaceutical Chemistry Laboratory, Istituto Superiore di Sanità, Rome, Italy.
Alimonti
S
S
Alimenti
R
R
De Sena
C
C
Signoretti
E C
EC
Draisci
R
R
Giannetti
L
L
D000658:Amoxicillin / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004340:Drug Contamination; D017022:Flow Injection Analysis; D013058:Mass Spectrometry
D000658:Amoxicillin